Alaska Native Communities Advancing Vaccine Uptake
阿拉斯加原住民社区促进疫苗接种
基本信息
- 批准号:10504537
- 负责人:
- 金额:$ 70.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-18 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAdultAdvocateAgeAlaskaAlaska NativeAlaskanAmerican IndiansAttitudeAwarenessBehaviorBeliefCOVID-19COVID-19 disparityCOVID-19 morbidityCOVID-19 mortalityCOVID-19 vaccinationCOVID-19 vaccineCommunitiesContractsDataDevelopmentEffectivenessEffectiveness of InterventionsEmotionalEnsureEvaluationFamilyFeedbackFriendsFutureGeneral PopulationGeographyGoalsGrainHealthHealth PlanningHealth PromotionHealth behavior changeHealth educationHospitalizationIncidenceIndividualInterventionInterviewKnowledgeMotivationNot Hispanic or LatinoParticipantPatternPersonsPopulationPrevalencePublic HealthQualitative MethodsQuasi-experimentRaceReach Effectiveness Adoption Implementation and MaintenanceReportingResearchRiskRuralSARS-CoV-2 infectionSocial NetworkSurveysTechnologyTestingTrainingTraining SupportUnited StatesUse EffectivenessVaccinatedVaccinationVaccinesWorkbasecohesiondesigneHealtheffectiveness evaluationevidence baseexperiencehealth organizationhuman old age (65+)membermortalitynovelnovel strategiesoutreachpeerprogramsrural Alaskarural areasocialtheoriestherapy designtooltribal healthuptakeurban areaurban residencevaccine acceptancevaccine distributionvaccine hesitancyvolunteerweb-based tool
项目摘要
PROJECT SUMMARY
Alaska Native and American Indian (ANAI) communities are experiencing a disproportionate share of SARS-
CoV-2 infection and its sequelae in the US. As of September 2021, ANAI people had a cumulative incidence of
9,256 COVID-19 cases per 100,000, compared with 5,445 among non-Hispanic Whites. The current rate of
COVID-19 associated deaths per 100,000 population is 220 among ANAI people, compared with 137 among
non-Hispanic Whites. Widespread vaccination remains the best strategy to control COVID-19 morbidity and
mortality, but the US has one of the lowest vaccine acceptance rates in the world with wide regional variability.
Little research has attempted to understand or address barriers to COVID-19 vaccination in ANAI people,
despite unique geographical, historical, and cultural factors that could influence vaccine uptake in this
population. We have formed a consortium of Tribal health leaders from across Alaska to better understand
vaccine attitudes and intentions, including hesitancy, and to increase vaccine uptake in Alaskan ANAI
communities. In conjunction with community advisors, we will develop and implement a theory-driven
intervention that is grounded in ANAI values of relationality and respect. First, we will use vaccination tracking
data to assess current rates of vaccine uptake and analyze preexisting quantitative and qualitative data
regarding vaccine attitudes, intentions, and behavior among ANAI people in rural and urban areas of Alaska.
We will also conduct a survey in southcentral Alaska to inform intervention design. Second, we will work with
statewide Tribal health leaders and regional Community Advisory Boards to create educational information,
stories, and messages keyed to the beliefs and perceived norms that drive vaccine behavior. This content will
be incorporated into an eHealth toolkit for use by community members and specially trained community
vaccine advocates, laypeople who volunteer to provide information and motivational/emotional support to their
friends, families, and communities. Third, we will launch the intervention in the southcentral region of Alaska
and evaluate effectiveness using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-
AIM) framework. Refinements based on program data and participant feedback will be made, then the refined
intervention will be deployed in two rural regions of Alaska and evaluated. This project will add to the limited
evidence base regarding adult vaccine attitudes, intentions, and behaviors among ANAI people. It holds the
potential to increase vaccination in a hard-hit population and build support for future vaccination as
SARS-CoV2 continues to evolve. Our findings will have broader applicability to vaccine outreach and
engaging ANAI communities in leveraging peer relationships, their social networks, and eHealth to promote
health education and behavior change.
项目摘要
阿拉斯加土著和美洲印第安人(ANAI)社区正在经历SARS-
COV-2感染及其后遗症在美国。截至2021年9月,Anai人的累积发生率
在非西班牙裔白人中,每100,000例Covid-19案例为9,256例,为5,445例。当前的速度
COVID-19与每10万人人口相关的死亡人口为220,而Anai人为137
非西班牙裔白人。广泛的疫苗接种仍然是控制共同发病率和
死亡率,但美国是世界上最低的疫苗接收率之一,其区域可变性很大。
很少有研究试图理解或解决Anai人群疫苗接种的障碍,
尽管独特的地理,历史和文化因素可能会影响疫苗的吸收
人口。我们组成了来自阿拉斯加各地的部落健康领导人的财团,以更好地了解
疫苗的态度和意图,包括犹豫,并增加阿拉斯加ANAI的疫苗接种
社区。与社区顾问一起,我们将开发和实施以理论为导向的
基于关系和尊重的Anai值的干预措施。首先,我们将使用疫苗接种跟踪
数据以评估疫苗摄取的当前速率并分析已经存在的定量和定性数据
关于阿拉斯加农村和城市地区的Anai人的疫苗态度,意图和行为。
我们还将在阿拉斯加中西部进行一项调查,以告知干预设计。其次,我们将与
全州部落健康领导者和区域社区咨询委员会,以创建教育信息,
故事以及信息的信念和感知的规范推动了疫苗行为。这个内容将
被纳入eHealth工具包中,供社区成员和经过特殊培训的社区使用
疫苗倡导者,外行者自愿为其提供信息和动机/情感支持
朋友,家人和社区。第三,我们将在阿拉斯加中西部地区发起干预措施
并使用覆盖范围,有效性,采用,实施和维护来评估有效性(重新
目标)框架。将根据程序数据和参与者的反馈进行改进,然后进行精制
干预将在阿拉斯加的两个农村地区部署并进行评估。该项目将增加有限
关于成年疫苗态度,意图和行为的证据基础。它持有
潜力增加遭受艰苦的人口的疫苗接种并为未来的疫苗接种建立支持
SARS-COV2继续发展。我们的发现将在疫苗外展和
吸引Anai社区利用同伴关系,社交网络和EHealth促进
健康教育和行为改变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann D Collier其他文献
Ann D Collier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann D Collier', 18)}}的其他基金
Building Capacity for Dissemination and Implementation Research in a Tribal Healthcare System
部落医疗保健系统传播和实施研究的能力建设
- 批准号:
10494079 - 财政年份:2021
- 资助金额:
$ 70.88万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
- 批准号:
10711136 - 财政年份:2023
- 资助金额:
$ 70.88万 - 项目类别:
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 70.88万 - 项目类别:
Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma
SARS-CoV-2 感染对患有和不患有哮喘的儿童呼吸道病毒免疫反应的影响
- 批准号:
10568344 - 财政年份:2023
- 资助金额:
$ 70.88万 - 项目类别:
Origin and host adaptation of the novel canine coronavirus (CCoV-HuPn-2018) isolated from a human pneumonia patient
从人类肺炎患者身上分离出的新型犬冠状病毒(CCoV-HuPn-2018)的起源和宿主适应
- 批准号:
10593314 - 财政年份:2023
- 资助金额:
$ 70.88万 - 项目类别: